Medium-chain triglycerides
Highest phase reached
Phase 3
Drug type
Unknown
- Listing at source
- Listed
- Highest phase reached
- Phase 3
- Drug type
- Unknown
- Drug name
- Medium-chain triglycerides
- medium chain triglycerides component of smoflipid
- Medium-chain triglycerides component of smoflipid
- miglyol 810 n
- Miglyol 810 n
- neobee 1053
- Neobee 1053
- caprylic and capric triglycerides
- Caprylic and capric triglycerides
- caprylic capric triglyceride
- caprylic capric triglyceride ii
- caprylic capric triglyceride who dd
- caprylic capric triglycerides
- Caprylic/capric triglyceride
- CAPRYLIC/CAPRIC TRIGLYCERIDE [II]
- Caprylic/capric triglyceride [WHO-DD]
- CAPRYLIC/CAPRIC TRIGLYCERIDES
- caprylocaproyl triglycerides
- CAPRYLOCAPROYL TRIGLYCERIDES
- captrin
- CAPTRIN
- coconut oil fractioned
- COCONUT OIL, FRACTIONED
- fractionated coconut oil
- FRACTIONATED COCONUT OIL
- FRACTIONATED COCONUT OIL [II]
- fractionated coconut oil ii
- fractionated triglyceride of coconut oil
- FRACTIONATED TRIGLYCERIDE OF COCONUT OIL
- glyceryl tricaprylocaprate
- GLYCERYL TRICAPRYLOCAPRATE
- liquid coconut oil
And 33 more, listed on the interactive page.
- CAS registry numbers
- 438544-49-1
- ChEMBL ID
- CHEMBL4298042
- PubChem compound IDs
- 91757308
- RxNorm IDs (RxCUI)
- 1310578
- FDA ingredient codes (UNII)
- C9H2L21V7U
- First in class
- No
- Orphan designation
- No
- Condition identifier
- EFO_0006834
- Highest recorded phase
- 1
- Condition identifier
- EFO_0007352
- Condition identifier
- EFO_1000653
- Condition identifier
- HP_0100806
- Highest recorded phase
- 1
- Condition identifier
- MONDO_0001751
- Highest recorded phase
- 3
- Condition identifier
- MONDO_0004979
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005154
- Highest recorded phase
- 4
- Condition identifier
- MONDO_0005833
- Highest recorded phase
- 4
- Event
- bacillus bacteraemia
- Reports
- 3
- Reporting signal score
- 18.4807
- Event
- bacteraemia
- Reports
- 4
- Reporting signal score
- 6.80991
- Event
- bacterial sepsis
- Reports
- 4
- Reporting signal score
- 13.9357
- Event
- blood potassium increased
- Reports
- 4
- Reporting signal score
- 6.45906
- Event
- body temperature increased
- Reports
- 7
- Reporting signal score
- 12.9046
- Event
- cheilitis
- Reports
- 4
- Reporting signal score
- 10.5307
- Event
- cholestasis
- Reports
- 14
- Reporting signal score
- 30.6707
- Event
- device programming error
- Reports
- 3
- Reporting signal score
- 16.488
- Event
- enterobacter infection
- Reports
- 2
- Reporting signal score
- 6.18293
- Event
- enterococcal bacteraemia
- Reports
- 2
- Reporting signal score
- 7.13149
- Event
- fat overload syndrome
- Reports
- 1
- Reporting signal score
- 7.94832
- Event
- fatigue
- Reports
- 1
- Reporting signal score
- 8.96549
- Event
- fatty acid deficiency
- Reports
- 26
- Reporting signal score
- 213.221
- Event
- food craving
- Reports
- 3
- Reporting signal score
- 10.2236
- Event
- fungaemia
- Reports
- 2
- Reporting signal score
- 6.41379
- Event
- growth failure
- Reports
- 2
- Reporting signal score
- 8.75558
- Event
- hyperbilirubinaemia
- Reports
- 4
- Reporting signal score
- 6.80242
- Event
- hyperglycaemia
- Reports
- 6
- Reporting signal score
- 6.82993
- Event
- hypertriglyceridaemia
- Reports
- 11
- Reporting signal score
- 33.8935
- Event
- hypoglycaemia
- Reports
- 7
- Reporting signal score
- 6.57345
- Event
- lactobacillus infection
- Reports
- 3
- Reporting signal score
- 17.4961
- Event
- lactobacillus test positive
- Reports
- 4
- Reporting signal score
- 30.5379
- Event
- liver function test increased
- Reports
- 5
- Reporting signal score
- 6.77669
- Event
- malaise
- Reports
- 24
- Reporting signal score
- 13.1509
- Event
- malassezia infection
- Reports
- 3
- Reporting signal score
- 21.535
And 18 more, listed on the interactive page.
- Prodrug
- No
- Inorganic
- No
- Natural product
- No
- 63323-820
Related records
Trials (61)
- 3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes
- A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
- A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults
- A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
- A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
- Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease
- An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
- Anrikefon-based Patient-controlled Intravenous Analgesia After Laparoscopic Surgery
- Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery
- Clinical Efficacy in Relieving Dentin Hypersensitivity of Nanohydroxyapatite-Containing Toothpastes and Cream
- Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct
- Comparison of Two Embryo Culture Media for IVF and ICSI
- Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization
- Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD)
- Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
- Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida
- Efficacy and Safety of a Fish Oil Containing Lipid Emulsion
- Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
- Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above
- EmbryoGlue as an Embryo Transfer Medium
Other linked conditions (1)
- Lymphatic system disorder